BlueDot, a Toronto, Canada-based digital health company that uses big data analytics to track and anticipate the spread of the world’s most dangerous infectious diseases, closed a $7M Series A financing.
The round, which brings BlueDot’s total funding to $9.5M, was co-led by The Co-operators and BDC Capital’s Women in Technology Venture Fund, with participation from existing investor Horizons Ventures. As part of the agreement, The Co-operators and BDC Capital will join BlueDot’s board of directors.
The company intends to use the funds to:
- develop its AI-driven product suite,
- grow its sales and commercialization efforts in government, healthcare, and insurance, and
- expand into new global markets.
Led by Dr. Kamran Khan, Founder and CEO, BlueDot enables governments to protect their citizens, hospitals protect their staff and patients, and businesses protect their employees and customers combining human and artificial intelligence to build solutions that track, contextualize, and anticipate infectious disease risks.
The company deployed its BlueDot Insights product, a global infectious disease surveillance and early warning system, in several hospitals across North America, 12 public health agencies around the world, and within Air Canada, a major international airline carrier.